Advertisement

Topics

Sinclair Pharma Plc SPH Financial and Strategic SWOT Analysis Review [Report Updated: 26092017] Prices from USD $125

08:05 EDT 29 Sep 2017 | BioPortfolio Report Blog

Sinclair Pharma Plc SPH Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.

Highlights

Sinclair Pharma plc Sinclair, formerly Sinclair IS Pharma plc, is an aesthetics company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatological products for facial aesthetics, particularly for facial rejuvenation, through collagen stimulation. It offers complementary aesthetics technologies; and longer duration, natural looking and minimallyinvasive treatments. It also offers dermal fillers for folds and lines. Some of Sinclair's major products include Silhouette Soft; Ellanse; Perfectha and Sculptra. It has direct sales and marketing presence in five major European countries and Brazil. It also has multiproduct and multicountry distribution partnerships with several companies. Sinclair is headquartered in London, the UK.

Sinclair Pharma Plc Key Recent Developments

Sep 19,2017: Sinclair Pharma: Interim Results
Jul 11,2017: Sinclair Pharma: Trading Update for the 6 months to 30 June 2017
Mar 30,2017: Sinclair Pharma: Additional listing
Mar 21,2017: Sinclair Pharma Announces Preliminary results for the 12 and 18 months ended 31 December 2016
Jan 17,2017: Sinclair Pharma Announces PreClose Trading Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Sinclair Pharma Plc SPH Financial and Strategic SWOT Analysis Review [Report Updated: 26092017] Prices from USD $125

NEXT ARTICLE

More From BioPortfolio on "Sinclair Pharma Plc SPH Financial and Strategic SWOT Analysis Review [Report Updated: 26092017] Prices from USD $125"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.